Safety Profile of Apixaban For Peri-Procedural Anticoagulation In Heart Transplant Recipients Undergoing Endomyocardial Biopsy
Endomyocardial biopsy (EMB) is routinely performed for surveillance of allograft rejection following heart transplantation (HTx). HTx recipients who are on anticoagulation are at higher risk for complications such as bleeding at access site, pericardial effusion, and cardiac tamponade. The safety of apixaban for periprocedural anticoagulation in heart transplant recipients undergoing EMB is not well characterized.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Daniel Daehyun Kim, Nicolas Krepostman, Dalila Masic, Shannon Kuhrau, Eugenia Raichlin, Max Liebo, Alain Heroux, Haseeb Ilias Basha Tags: 114 Source Type: research
More News: Bleeding | Bone Graft | Cardiology | Heart | Heart Transplant | Transplant Surgery | Transplants